share_log

4: Statement of changes in beneficial ownership of securities-Director Allen Charles W

4: Statement of changes in beneficial ownership of securities-Director Allen Charles W

4：持股變動聲明-董事 Allen Charles W
美股sec公告 ·  05/22 08:20
牛牛AI助理已提取核心訊息
On May 16, 2024, Charles W. Allen, associated with 60 Degrees Pharmaceuticals, completed a purchase of 4,000 shares of the company's common stock. The transaction was executed at a price of $0.223 per share. Following this acquisition, Allen's direct holdings in the company increased to a total of 14,000 shares. The transaction is categorized as an exercise or conversion of derivative security, and it reflects Allen's growing stake in the pharmaceutical company.
On May 16, 2024, Charles W. Allen, associated with 60 Degrees Pharmaceuticals, completed a purchase of 4,000 shares of the company's common stock. The transaction was executed at a price of $0.223 per share. Following this acquisition, Allen's direct holdings in the company increased to a total of 14,000 shares. The transaction is categorized as an exercise or conversion of derivative security, and it reflects Allen's growing stake in the pharmaceutical company.
2024年5月16日，與60度製藥相關的查爾斯·艾倫完成了對該公司4,000股普通股的收購。該交易以每股0.223美元的價格執行。此次收購後，艾倫在該公司的直接持股量增加到總計14,000股。該交易被歸類爲衍生證券的行使或轉換，它反映了艾倫在這家制藥公司的股份不斷增加。
2024年5月16日，與60度製藥相關的查爾斯·艾倫完成了對該公司4,000股普通股的收購。該交易以每股0.223美元的價格執行。此次收購後，艾倫在該公司的直接持股量增加到總計14,000股。該交易被歸類爲衍生證券的行使或轉換，它反映了艾倫在這家制藥公司的股份不斷增加。
有用
沒用

該公告為獨立文件：

獨立文件1

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。